Targeting P-Glycoprotein Function, P53 and Energy Metabolism: Combination of Metformin and 2-Deoxyglucose Reverses the Multidrug Resistance of McF-7/Dox Cells to Doxorubicin

Oncotarget - United States
doi 10.18632/oncotarget.14373
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

NVP-TAE684 Reverses Multidrug Resistance (MDR) in Human Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function

British Journal of Pharmacology
Pharmacology
2016English

HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein

PLoS ONE
Multidisciplinary
2014English

P‐Glycoprotein, Multidrug Resistance and Protein Kinase C

Oncologist
Cancer ResearchMedicineOncology
1996English

MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1

Oncology Letters
Cancer ResearchOncology
2017English

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells Through Regulating the Tumor Metabolism

PLoS ONE
Multidisciplinary
2016English

miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1

Cancer Management and Research
Oncology
2019English

Crown Ethers Reverse P-Glycoprotein-Mediated Multidrug Resistance in Cancer Cells

Scientific Reports
Multidisciplinary
2018English

ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2018English

Effect of Recombinant Human Erythropoietin and Doxorubicin in Combination on the Proliferation of McF-7 and MDA-MB231 Breast Cancer Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy